Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Zemel

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
Kidney International|November 1, 1994
Appearance of tumor necrosis factor-alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPDD Zemel, A L Imholz, D R de Waart, et al.
The Journal of Laboratory and Clinical Medicine|August 1, 1995
Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysisD Zemel, D G Struijk, C Dinkla, et al.
The Journal of Laboratory and Clinical Medicine|December 1, 1993
Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysisD Zemel, G C Koomen, A A Hart, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Interleukin-8 during peritonitis in patients treated with CAPD; an in-vivo model of acute inflammationD Zemel, R T Krediet, G C Koomen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Analysis of the peritoneal cellular immune system during CAPD shortly before a clinical peritonitisM G Betjes, C W Tuk, C E Visser, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1996
Impaired initial cell reaction in CAPD-related peritonitisJ G Koopmans, E W Boeschoten, M M Pannekeet, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1995
Nitrate in stable CAPD patients and during peritonitisC E Douma, D R de Waart, D Zemel, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 1, 1996
Intraperitoneal interleukin-8 and neutrophil influx in the initial phase of a CAPD peritonitisM G Betjes, C E Visser, D Zemel, et al.
Multiple Sclerosis and Related Disorders|November 29, 2020
Diffuse alveolar hemorrhage as an early complication of alemtuzumab treatment: A case report of a multiple sclerosis patient and an overview of 14 casesB R H Drop, D Zemel, B H A Wokke, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Coping strategies in relation to negative work events and accommodations in employed multiple sclerosis patientsK van der Hiele, Dam van Gorp, Rhb Benedict, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
Kidney International|November 1, 1994
Appearance of tumor necrosis factor-alpha and soluble TNF-receptors I and II in peritoneal effluent of CAPDD Zemel, A L Imholz, D R de Waart, et al.
The Journal of Laboratory and Clinical Medicine|August 1, 1995
Effects of intraperitoneal cyclooxygenase inhibition on inflammatory mediators in dialysate and peritoneal membrane characteristics during peritonitis in continuous ambulatory peritoneal dialysisD Zemel, D G Struijk, C Dinkla, et al.
The Journal of Laboratory and Clinical Medicine|December 1, 1993
Relationship of TNF-alpha, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysisD Zemel, G C Koomen, A A Hart, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Interleukin-8 during peritonitis in patients treated with CAPD; an in-vivo model of acute inflammationD Zemel, R T Krediet, G C Koomen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1994
Analysis of the peritoneal cellular immune system during CAPD shortly before a clinical peritonitisM G Betjes, C W Tuk, C E Visser, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|January 1, 1996
Impaired initial cell reaction in CAPD-related peritonitisJ G Koopmans, E W Boeschoten, M M Pannekeet, et al.
Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis|January 1, 1995
Nitrate in stable CAPD patients and during peritonitisC E Douma, D R de Waart, D Zemel, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|July 1, 1996
Intraperitoneal interleukin-8 and neutrophil influx in the initial phase of a CAPD peritonitisM G Betjes, C E Visser, D Zemel, et al.
Multiple Sclerosis and Related Disorders|November 29, 2020
Diffuse alveolar hemorrhage as an early complication of alemtuzumab treatment: A case report of a multiple sclerosis patient and an overview of 14 casesB R H Drop, D Zemel, B H A Wokke, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|June 14, 2017
Coping strategies in relation to negative work events and accommodations in employed multiple sclerosis patientsK van der Hiele, Dam van Gorp, Rhb Benedict, et al.
Pageof 3